Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics ; volume:3 ; number:1 ; day:21 ; month:4 ; year:2015 ; pages:1-7 ; date:12.2015
Journal for ImmunoTherapy of Cancer ; 3, Heft 1 (21.4.2015), 1-7, 12.2015
- Urheber
-
Sayour, Elias J.
- Beteiligte Personen und Organisationen
-
Sanchez-Perez, Luis
Flores, Catherine
Mitchell, Duane A.
SpringerLink (Online service)
- DOI
-
10.1186/s40425-015-0058-0
- URN
-
urn:nbn:de:1111-201610305323
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sayour, Elias J.
- Sanchez-Perez, Luis
- Flores, Catherine
- Mitchell, Duane A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immunotherapy and vaccines
Targeted transduction of T cell subsets for immunotherapy of cancer and infectious disease
Immunotherapy and vaccination against infectious diseases
Combination therapies utilizing neoepitope-targeted vaccines
Developing vaccines against epidemic-prone emerging infectious diseases
Communicating Benefits from Vaccines Beyond Preventing Infectious Diseases
BCMA-targeted immunotherapy for multiple myeloma
The quest for nanoparticle-powered vaccines in cancer immunotherapy
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Research progress on dendritic cell vaccines in cancer immunotherapy
Telomerase-based vaccines: a promising frontier in cancer immunotherapy
Live vaccines—a short‐cut to cancer viro‐immunotherapy
Immunotherapy and vaccines
Targeted transduction of T cell subsets for immunotherapy of cancer and infectious disease
Immunotherapy and vaccination against infectious diseases
Combination therapies utilizing neoepitope-targeted vaccines
Developing vaccines against epidemic-prone emerging infectious diseases
Communicating Benefits from Vaccines Beyond Preventing Infectious Diseases
BCMA-targeted immunotherapy for multiple myeloma
The quest for nanoparticle-powered vaccines in cancer immunotherapy
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Research progress on dendritic cell vaccines in cancer immunotherapy
Telomerase-based vaccines: a promising frontier in cancer immunotherapy
Live vaccines—a short‐cut to cancer viro‐immunotherapy
Immunotherapy and vaccines
Targeted transduction of T cell subsets for immunotherapy of cancer and infectious disease
Immunotherapy and vaccination against infectious diseases
Combination therapies utilizing neoepitope-targeted vaccines
Developing vaccines against epidemic-prone emerging infectious diseases
Communicating Benefits from Vaccines Beyond Preventing Infectious Diseases
BCMA-targeted immunotherapy for multiple myeloma
The quest for nanoparticle-powered vaccines in cancer immunotherapy
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Research progress on dendritic cell vaccines in cancer immunotherapy
Telomerase-based vaccines: a promising frontier in cancer immunotherapy